OncLive Summit Looks at Ovarian Cancer and Soft Tissue Sarcoma

OncLive Summit Looks at Ovarian Cancer and Soft Tissue Sarcoma
A recent OncLive State of the Science Summit focused on new therapies and other issues in ovarian cancer and soft tissue sarcoma. The March 26 event in New York was chaired by Mario M. Leitao Jr., MD, fellowship director of gynecology service and director of the minimal access and robotic surgery program at Memorial Sloan Kettering Cancer Center. A podcast of the event is upcoming on the OncLive On Air site, where other podcasts can also be found. In addition to a question-and-answer session and peer-exchange discussion, experts examined ovarian cancer topics such as molecular testing, surgical options for the newly diagnosed, maintenance therapy and immunotherapy in advanced disease, and therapies for recurrent cancer. They also discussed metastatic
Subscribe or to access all post and page content.